Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men

Journal of Physiology

Volumn 592, Issue 8, 2014, Pages 1873-1886

  Olesen, Jesper ^a   Gliemann, Lasse ^a   Biensø, Rasmus ^a   Schmidt, Jakob ^a   Hellsten, Ylva ^a   Pilegaard, Henriette ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CITRATE SYNTHASE; CYTOCHROME C; CYTOCHROME C OXIDASE 1; I KAPPA B ALPHA; I KAPPA B BETA; MESSENGER RNA; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLACEBO; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYCLOOXYGENASE 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; I KAPPA B; PPARGC1A PROTEIN, HUMAN; PTGS1 PROTEIN, HUMAN; STILBENE DERIVATIVE; TRANSCRIPTION FACTOR;

ACETYLATION; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDURANCE TRAINING; ENZYME ACTIVITY; EXERCISE; EXERCISE INTENSITY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INFLAMMATION; MALE; MUSCLE BIOPSY; MUSCLE METABOLISM; NORMAL HUMAN; PATIENT COMPLIANCE; PHYSICAL INACTIVITY; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN CONTENT; RANDOMIZED CONTROLLED TRIAL; BLOOD; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; SKELETAL MUSCLE;

AGED; CITRATE (SI)-SYNTHASE; CYCLOOXYGENASE 1; DOUBLE-BLIND METHOD; EXERCISE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; I-KAPPA B PROTEINS; MALE; MUSCLE, SKELETAL; STILBENES; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898543412     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.270256     Document Type: Article

References (70)

1. Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP & Holloszy JO (2002). Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 16, 1879-1886.
2. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couter D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R & Sinclair DA (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342.
3. Bergstrom J (1975). Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35, 609-616.
4. Birk JB & Wojtaszewski JF (2006). Predominant α2/β2/γ3 AMPK activation during exercise in human skeletal muscle. J Physiol 577, 1021-1032.
5. Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, Mikolás E, Szijártó IA, Mérei A, Halmai R, Mészáros LG, Sümegi B & Wittmann I (2011). Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 106, 383-389.
6. Chabi B, Ljubicic V, Menzies KJ, Huang JH, Saleem A & Hood DA (2008). Mitochondrial function and apoptotic susceptibility in aging skeletal muscle. Aging Cell 7, 2-12.
7. Chomczynski P & Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156-159.
8. Conley KE, Jubrias SA & Esselman PC (2000). Oxidative capacity and ageing in human muscle. J Physiol 526, 203-210.
9. Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, Cohen HW & Barzilai N (2012). Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 67, 1307-1312.
10. Dolinsky VW, Jones KE, Sidhu RS, Haykowsky M, Czubryt MP, Gordon T & Dyck JR (2012). Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats. J Physiol 590, 2783-2799.
11. Frontera WR, Meredith CN, O'Reilly KP, Knuttgen HG & Evans WJ (1988). Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J Appl Physiol 64, 1038-1044.
12. Geng T, Li P, Okutsu M, Yin X, Kwek J, Zhang M & Yan Z (2010). PGC-1α plays a functional role in exercise-induced mitochondrial biogenesis and angiogenesis but not fibre-type transformation in mouse skeletal muscle. Am J Physiol Cell Physiol 298, C572-C579.
13. Ghosh S, Lertwattanarak R, Lefort N, Molina-Carrion M, Joya-Galeana J, Bowen BP, Garduno-Garcia Jde J, Abdul-Ghani M, Richardson A, DeFronzo RA, Mandarino L, Van Remmen H & Musi N (2011). Reduction in reactive oxygen species production by mitochondria from elderly subjects with normal and impaired glucose tolerance. Diabetes 60, 2051-2060.
14. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS & Nimmo MA (2011). The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 11, 607-615.
15. Gliemann L, Schmidt JF, Olesen J, Biensø RS, Peronard SL, Grandjean SU, Mortensen SP, Nyberg M, Bangsbo J, Pilegaard H & Hellsten Y (2013). Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol 591, 5047-5059.
16. Gollnick PD, Armstrong RB, Saltin B, Saubert CW 4th, Sembrowich WL & Shepherd RE (1973). Effect of training on enzyme activity and fiber composition of human skeletal muscle. J Appl Physiol 34, 107-111.
17. Gomez-Cabrera MC, Domenech E, Romagnoli M, Arduini A, Borras C, Pallardo FV, Sastre J & Viña J (2008). Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance. Am J Clin Nutr 87, 142-149.
18. Handschin C, Choi CS, Chin S, Kim S, Kawamori D, Kurpad AJ, Neubauer N, Hu J, Mootha VK, Kim YB, Kulkarni RN, Shulman GI & Spiegelman BM (2007). Abnormal glucose homeostasis in skeletal muscle-specific PGC-1α knockout mice reveals skeletal muscle-pancreatic β cell crosstalk. J Clin Invest 117, 3463-3474.
19. Handschin C & Spiegelman BM (2008). The role of exercise and PGC1α in inflammation and chronic disease. Nature 454, 463-469.
20. Henriksson J & Reitman JS (1977). Time course of changes in human skeletal muscle succinate dehydrogenase and cytochrome oxidase activities and maximal oxygen uptake with physical activity and inactivity. Acta Physiol Scand 99, 91-97.
21. Higashida K, Kim SH, Jung SR, Asaka M, Holloszy JO & Han DH (2013). Effects of resveratrol and SIRT1 on PGC-1α activity and mitochondrial biogenesis: a reevaluation. PLoS Biol 11, e1001603.
22. Hollmann W, Strüder HK, Tagarakis CV & King G (2007). Physical activity and the elderly. Eur J Cardiovasc Prev Rehabil 14, 730-739.
23. Holloszy JO (1967). Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 242, 2278-2282.
24. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B & Sinclair DA (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.
25. Iversen N, Krustrup P, Rasmussen HN, Rasmussen UF, Saltin B & Pilegaard H (2011). Mitochondrial biogenesis and angiogenesis in skeletal muscle of the elderly. Exp Gerontol 46, 670-678.
26. Jackson JR, Ryan MJ & Alway SE (2011). Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice. J Gerontol A Biol Sci Med Sci 66, 751-764.
27. Jackson MJ, Papa S, Bolaños J, Bruckdorfer R, Carlsen H, Elliott RM, Flier J, Griffiths HR, Heales S, Holst B, Lorusso M, Lund E, Øivind Moskaug J, Moser U, Di Paola M, Polidori MC, Signorile A, Stahl W, Viña-Ribes J & Astley SB (2002). Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol Aspects Med 23, 209-285.
28. Juan ME, Vinardell MP & Planas JM (2002). The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 132, 257-260.
29. Kim HJ, Park KG, Yoo EK, Kim YH, Kim YN, Kim HS, Kim HT, Park JY, Lee KU, Jang WG, Kim JG, Kim BW & Lee IK (2007). Effects of PGC-1alpha on TNF-alpha-induced MCP-1 and VCAM-1 expression and NF-kappaB activation in human aortic smooth muscle and endothelial cells. Antioxid Redox Signal 9, 301-307.
30. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P & Auwerx J (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127, 1109-1122.
31. Leick L, Lyngby SS, Wojtaszewski JF & Pilegaard H (2010). PGC-1α is required for training-induced prevention of age-associated decline in mitochondrial enzymes in mouse skeletal muscle. Exp Gerontol 45, 336-342.
32. Leick L, Wojtaszewski JF, Johansen ST, Kiilerich K, Comes G, Hellsten Y, Hidalgo J & Pilegaard H (2008). PGC-1α is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle. Am J Physiol Endocrinol Metab 294, E463-E474.
33. Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jäger S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, Lowell BB, Krainc D & Spiegelman BM (2004). Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice. Cell 119, 121-135.
34. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R & Spiegelman BM (2002). Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418, 797-801.
35. Ling C, Poulsen P, Carlsson E, Ridderstråle M, Almgren P, Wojtaszewski J, Beck-Nielsen H, Groop L & Vaag A (2004). Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins. J Clin Invest 114, 1518-1526.
36. Loh K, Deng H, Fukushima A, Cai X, Boivin B, Galic S, Bruce C, Shields BJ, Skiba B, Ooms LM, Stepto N, Wu B, Mitchell CA, Tonks NK, Watt MJ, Febbraio MA, Crack PJ, Andrikopoulos S & Tiganis T (2009). Reactive oxygen species enhance insulin sensitivity. Cell Metab 10, 260-272.
37. Lowry CV, Kimmey JS, Felder S, Chi MM, Kaiser KK, Passonneau PN, Kirk KA & Lowry OH (1978). Enzyme patterns in single human muscle fibers. J Biol Chem 253, 8269-8277.
38. Lundby C, Nordsborg N, Kusuhara K, Kristensen KM, Neufer PD & Pilegaard H (2005). Gene expression in human skeletal muscle: alternative normalization method and effect of repeated biopsies. Eur J Appl Physiol 95, 351-360.
39. Masoro EJ (2001). Physiology of aging. Int J Sport Nutr Exerc Metab 11 Suppl, S218-S222.
40. Menzies KJ, Singh K, Saleem A & Hood DA (2013). Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis. J Biol Chem 288, 6968-6979.
41. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL & Strong R (2011). Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 66, 191-201.
42. Nordsborg NB, Lundby C, Leick L & Pilegaard H (2010). Relative workload determines exercise-induced increases in PGC-1α mRNA. Med Sci Sports Exerc 42, 1477-1484.
43. Olas B & Wachowicz B (2005). Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets 16, 251-260.
44. Olesen J, Ringholm S, Nielsen MM, Brandt CT, Pedersen JT, Halling JF, Goodyear LJ & Pilegaard H (2013). Role of PGC-1α in exercise training- and resveratrol-induced prevention of age-associated inflammation. Exp Gerontol 48, 1274-1284.
45. Olholm J, Paulsen SK, Cullberg KB, Richelsen B & Pedersen SB (2010). Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int J Obes (Lond) 34, 1546-1553.
46. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V & Chung JH (2012). Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421-433.
47. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couter D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA & de Cabo R (2008). Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8, 157-168.
48. Pedersen BK & Saltin B (2006). Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 16 Suppl 1, 3-63.
49. Pilegaard H, Ordway GA, Saltin B & Neufer PD (2000). Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 279, E806-E814.
50. Pilegaard H, Saltin B & Neufer PD (2003). Exercise induces transient transcriptional activation of the PGC-1α gene in human skeletal muscle. J Physiol 546, 851-858.
51. Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stødkilde-Jørgensen H, Møller N, Jessen N, Pedersen SB & Jørgensen JO (2012). High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62, 1186-1195.
52. Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA & Sinclair DA (2012). SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15, 675-690.
53. Ringholm, Olesen J, Pedersen J, Brandt C, Halling J, Hellsten Y, Prats C & Pilegaard H (2013). Effect of lifelong resveratrol supplementation and exercise training on skeletal muscle oxidative capacity in aging mice; impact of PGC-1α. Exp Gerontol 48, 1311-1318.
54. Ristow M, Zarse K, Oberbach A, Kloting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR & Blüher M (2009). Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A 106, 8665-8670.
55. Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, Gobelet C, Meier CA, Bell DR, Kralli A, Giacobino JP & Dériaz O (2003). Endurance training in humans leads to fibre type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle. Diabetes 52, 2874-2881.
56. Schenk S, Harber MP, Shrivastava CR, Burant CF & Horowitz JF (2009). Improved insulin sensitivity after weight loss and exercise training is mediated by a reduction in plasma fatty acid mobilization, not enhanced oxidative capacity. J Physiol 587, 4949-4961.
57. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM & Nair KS (2003). Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52, 1888-1896.
58. Skrobuk P, von Kraemer S, Semenova MM, Zitting A & Koistinen HA (2012). Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells. Diabetologia 55, 3051-3060.
59. Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, DeFronzo RA, Mandarino LJ & Musi N (2006). Reduced skeletal muscle inhibitor of κBβ content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Diabetes 55, 760-767.
60. Stojanović S, Sprinz H & Brede O (2001). Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Arch Biochem Biophys 391, 79-89.
61. Strong R, Miller RA, Astle CM, Baur JA, de Cabo R, Fernandez E, Guo W, Javors M, Kirkland JL, Nelson JF, Sinclair DA, Teter B, Williams D, Zaveri N, Nadon NL & Harrison DE (2013). Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 68, 6-16.
62. Suominen H, Heikkinen E, Liesen H, Michel D & Hollmann W (1977). Effects of 8 weeks' endurance training on skeletal muscle metabolism in 56-70-year-old sedentary men. Eur J Appl Physiol Occup Physiol 37, 173-180.
63. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MK, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J & Schrauwen P (2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14, 612-622.
64. Turrens JF, Lariccia J & Nair MG (1997). Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats. Free Radic Res 27, 557-562.
65. Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B & Chung JH (2010). AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59, 554-563.
66. Walle T (2011). Bioavailability of resveratrol. Ann N Y Acad Sci 1215, 9-15.
67. Wende AR, Schaeffer PJ, Parker GJ, Zechner C, Han DH, Chen MM, Hancock CR, Lehman JJ, Huss JM, McClain DA, Holloszy JO & Kelly DP (2007). A role for the transcriptional coactivator PGC-1α in muscle refueling. J Biol Chem 282, 36642-36651.
68. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M & Sinclair D (2004). Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686-689.
69. Woods JA, Wilund KR, Martin SA & Kistler BM (2012). Exercise, inflammation and aging. Aging Dis 3, 130-140.
70. Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S, Schechtman KB, Gu C, Kunz I, Rossi FF, Patterson BW & Klein S (2012). Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab 16, 658-664.